These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32235391)

  • 1. Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites.
    de Sousa ACC; Maepa K; Combrinck JM; Egan TJ
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32235391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian models trained with HTS data for predicting β-haematin inhibition and in vitro antimalarial activity.
    Wicht KJ; Combrinck JM; Smith PJ; Egan TJ
    Bioorg Med Chem; 2015 Aug; 23(16):5210-7. PubMed ID: 25573118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual screening as a tool to discover new β-haematin inhibitors with activity against malaria parasites.
    de Sousa ACC; Combrinck JM; Maepa K; Egan TJ
    Sci Rep; 2020 Feb; 10(1):3374. PubMed ID: 32099045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte phagocytosis of malaria β-haematin in the presence of artemisinin, amodiaquine, chloroquine, doxycycline, primaquine, pyrimethamine and quinine.
    Cumming BM; Goldring JPD
    Exp Parasitol; 2019 Feb; 197():93-102. PubMed ID: 30562480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THC shows activity against cultured Plasmodium falciparum.
    de Sousa ACC; Combrinck JM; Maepa K; Egan TJ
    Bioorg Med Chem Lett; 2021 Dec; 54():128442. PubMed ID: 34763083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemozoin inhibiting 2-phenylbenzimidazoles active against malaria parasites.
    L'abbate FP; Müller R; Openshaw R; Combrinck JM; de Villiers KA; Hunter R; Egan TJ
    Eur J Med Chem; 2018 Nov; 159():243-254. PubMed ID: 30296683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
    Vijayaraghavan S; Mahajan S
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Biological Evaluation, and Molecular Modeling Studies of Chiral Chloroquine Analogues as Antimalarial Agents.
    Kondaparla S; Debnath U; Soni A; Dola VR; Sinha M; Srivastava K; Puri SK; Katti SB
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally occurring cobalamins have antimalarial activity.
    Chemaly SM; Chen CT; van Zyl RL
    J Inorg Biochem; 2007 May; 101(5):764-73. PubMed ID: 17343914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resonance Raman spectroscopy can detect structural changes in haemozoin (malaria pigment) following incubation with chloroquine in infected erythrocytes.
    Webster GT; Tilley L; Deed S; McNaughton D; Wood BR
    FEBS Lett; 2008 Apr; 582(7):1087-92. PubMed ID: 18325340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activities of nitidine, a potential anti-malarial lead compound.
    Bouquet J; Rivaud M; Chevalley S; Deharo E; Jullian V; Valentin A
    Malar J; 2012 Mar; 11():67. PubMed ID: 22404785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemozoin formation.
    Egan TJ
    Mol Biochem Parasitol; 2008 Feb; 157(2):127-36. PubMed ID: 18083247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying inhibitors of β-haematin formation with activity against chloroquine-resistant Plasmodium falciparum malaria parasites via virtual screening approaches.
    Amod L; Mohunlal R; Teixeira N; Egan TJ; Wicht KJ
    Sci Rep; 2023 Feb; 13(1):2648. PubMed ID: 36788274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel benzimidazole acrylonitriles for inhibition of Plasmodium falciparum growth by dual target inhibition.
    Sharma K; Shrivastava A; Mehra RN; Deora GS; Alam MM; Zaman MS; Akhter M
    Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29227011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin.
    Kalkanidis M; Klonis N; Tilley L; Deady LW
    Biochem Pharmacol; 2002 Mar; 63(5):833-42. PubMed ID: 11911834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Content Screening of the Medicines for Malaria Venture Pathogen Box for Plasmodium falciparum Digestive Vacuole-Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery.
    Tong JX; Chandramohanadas R; Tan KS
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311064
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.
    Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL
    Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theories on malarial pigment formation and quinoline action.
    Sullivan DJ
    Int J Parasitol; 2002 Dec; 32(13):1645-53. PubMed ID: 12435449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple and inexpensive haemozoin-based colorimetric method to evaluate anti-malarial drug activity.
    Men TT; Huy NT; Trang DT; Shuaibu MN; Hirayama K; Kamei K
    Malar J; 2012 Aug; 11():272. PubMed ID: 22877238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
    Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
    ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.